Mustang Bio
MBIO
27 hedge funds and large institutions have $774K invested in Mustang Bio in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
8% more funds holding
Funds holding: 25 → 27 (+2)
0.07% less ownership
Funds ownership: 0.23% → 0.16% (-0.07%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
45% less capital invested
Capital invested by funds: $1.41M → $774K (-$638K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$38.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.2K |
| 3 |
Squarepoint
New York
|
+$19K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$12.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$287K |
| 2 |
KOC
Koss-Olinger Consulting
Gainesville,
Florida
|
-$130K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$57.5K |
| 4 |
Morgan Stanley
New York
|
-$15.1K |
| 5 |
Renaissance Technologies
New York
|
-$5.46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $14 | – | – | – |
|
|
PCWA
27
Pacific Capital Wealth Advisors
Corona,
California
| $6 | – | – | – |
|
|
CPA
28
Clear Point Advisors
Melville,
New York
| $1 | – | – | – |
|
|
KOC
29
Koss-Olinger Consulting
Gainesville,
Florida
| – | -$130K | -1,927 | Closed |
|
|
30
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$57.5K | -852 | Closed |
|
31
US Bancorp
Minneapolis,
Minnesota
| – | -$1.35K | -20 | Closed |
|
|
OLVIG
32
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| – | -$12 | – | – |
|
|
CAL
33
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | +$127 | +2 | New |
|
MBIO Hedge Fund Activity: Q1 2024 in Review
27 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2024, worth a combined $774K — down 45% from $1.41M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MBIO positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $38.4K. The largest seller was Armistice Capital, cutting an estimated $287K.
- 27 institutional investors held Mustang Bio (MBIO) as of Q1 2024, up from 25 in Q4 2023.
- Funds reported $774K of Mustang Bio stock for Q1 2024, down 45% quarter-over-quarter.
- 5 funds opened new Mustang Bio positions in Q1 2024 and 3 closed out, a net change of +2 holders.
- The largest Mustang Bio buyer in Q1 2024 was Virtu Financial, an estimated $38.4K added.
- The largest Mustang Bio seller in Q1 2024 was Armistice Capital, an estimated $287K sold.
Based on aggregated 13F filings for Q1 2024.